Myeloproliferative Neoplasms (MPNs) Patient Registry
Recruiting
Observational Study
Primary Myelofibrosis
Polycythemia Vera
Essential Thrombocythemia
Mastocytosis
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Leukemia, Myelomonocytic, Juvenile
Chronic Eosinophilic Leukemia-not Otherwise Specified
Myelodysplastic-Myeloproliferative Diseases
Neoplasms
Leukemia, Myelomonocytic, Chronic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- University Health Network, Toronto · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Diagnosis of one of the following myeloproliferative neoplasms (MPNs):
* Atypical CML (aCML)
* Chronic eosinophilic leukemia-not otherwise specified (CEL, NOS),
* Chronic myelomonocytic leukemia (CMML)
* Chronic neutrophilic leukemia (CNL),
* Essential thrombocythemia (ET),
* J…
Contacts